| 糖尿病肾病诊断与治疗新进展 |
| |
| 引用本文： | 刘裔凯,罗说明,邓敏,周智广. 糖尿病肾病诊断与治疗新进展[J]. 中国动脉硬化杂志, 2020, 28(8): 688-691, 706 |
| |
| 作者姓名： | 刘裔凯 罗说明 邓敏 周智广 |
| |
| 作者单位： | 中南大学湘雅二医院代谢内分泌科 糖尿病免疫学教育部重点实验室 国家代谢性疾病临床医学研究中心,湖南省长沙市 410011 |
| |
| 基金项目： | 国家重点研发计划(2016YFC1305000,2016YFC1305002)；湖南省自然科学基金面上项目(2018JJ2573)；湖南省科技重大专项(2017SK1020) |
| |
| 摘 要： | 糖尿病是一组由环境与遗传等多种病因共同引起的以糖代谢紊乱为特征的代谢性疾病。糖尿病肾病(DN)是糖尿病患者最常见、最严重的慢性合并症。目前,糖尿病肾病约占糖尿病患者的40%,是全世界慢性肾病的主要原因。中国已是世界第一糖尿病大国,也是糖尿病肾病大国。本文就糖尿病肾病诊断与治疗方面的新研究进展进行综述,旨在提供有关DN诊断和治疗的最新信息。
|
| 关 键 词： | 糖尿病 糖尿病肾病 危险因素 生物学标志物 |
| 收稿时间： | 2020-04-10 |
| 修稿时间： | 2020-05-15 |
Progress in diagnosis and treatment of diabetic nephropathy |
| |
| LIU Yikai,LUO Shuoming,DENG Min,ZHOU Zhiguang. Progress in diagnosis and treatment of diabetic nephropathy[J]. Chinese Journal of Arteriosclerosis, 2020, 28(8): 688-691, 706 |
| |
| Authors: | LIU Yikai LUO Shuoming DENG Min ZHOU Zhiguang |
| |
| Affiliation: | Department of Metabolism and Endocrinology & Key Laboratory of Diabetes Immunology, Ministry of Education & National Clinical Research Center for Metabolic Diseases, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China |
| |
| Abstract: | Diabetes is a group of metabolic diseases characterized by disorders of glucose metabolism, which are caused by a variety of environmental and genetic causes. Diabetic nephropathy (DN) is the most common and severe chronic comorbidity in patients with diabetes. At present, diabetic nephropathy accounts for about 40% of diabetic patients, and is the main cause of chronic kidney disease (CKD) worldwide. At present, China is already the world''s largest country with diabetes and a country with diabetic nephropathy. This article reviews the new research progress in the diagnosis and treatment of diabetic nephropathy. Designed to provide the latest information on DN diagnosis and treatment. |
| |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《中国动脉硬化杂志》浏览原始摘要信息 |
|
点击此处可从《中国动脉硬化杂志》下载全文 |
|
